Manolis, Good and Shrank Address Abuse-Deterrent Opioids

2017-07-14T05:23:12-06:00May 26th, 2017|Viewpoints|

In the latest post on the IVI-sponsored Health Affairs blog series, Chronis Manolis, C. Bernie Good and William Shrank discuss current approaches to curbing rampant opioid abuse, including the mandating of coverage for abuse-deterrent opioids. The authors make the case that this tactic would be non-effective, costly and would distract from arriving at more comprehensive solutions among payer and provider stakeholders.

Read more here.

About the Health Affairs/IVI Featured Blog Series: Drugs and Medical Innovation — In partnership with Health Affairs, IVI is proud to sponsor the “Drugs and Medical Innovation” blog series. On an ongoing basis, articles in this series will explore topics such as value-based reimbursement, drug policy and pricing, balancing short-term access against long-term rates of innovation, and other relevant issues. Our goal is to create an open forum for sharing ideas and debating issues in these areas, extending the discussion to a broader audience.